The analysis of the correlations between the serum levels of PIVKA-II, ucMGP, CEA, and CA 19-9 was performed in patients with colorectal carcinoma with and without liver metastases in comparison with a control group. This evidence concerns the gene CEACAM5 and colorectal carcinoma.